Nuwellis Inc vs Visa Inc — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Visa Inc trades at $369.75 (market cap $693.57B). The key difference: Visa Inc is far larger — about 277428× Nuwellis Inc's market cap, and Visa Inc pays a 0.73% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | V | |
|---|---|---|
Market Cap | $2.50M | $693.57B |
Sector | Technology | Financials |
52-Week High | $164.50 | $384.14 |
52-Week Low | $0.73 | $295.52 |
Enterprise Value | -$1.21M | $704.15B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.73% |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Visa (V) trades at $368.64, down 1.71% on the day, but maintains strong fundamentals with a 50.78% net income margin and consistent earnings beats. The stock is supported by a bullish technical signal, with key support at $366 and resistance at $372. Recent developments include the launch of Intelligent Commerce Connect to facilitate AI-driven commerce, positioning the company for future growth amid digital payment expansion.
The outlook for Visa remains positive, driven by robust profitability, strategic AI initiatives, and a consensus price target of $430.93 implying 17% upside. Risks include competitive pressures from fintech and stablecoins, as well as regulatory scrutiny. Wall Street sentiment is overwhelmingly bullish with 85% of analysts rating it a Buy, supported by institutional accumulation.
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →